A2 Biotherapeutics
A2 is dedicated to advancing cancer treatment through pioneering cell therapy.
$80M Series B+ ·
Source: fundraisingfox.com
Total raised: $270.5M across 4 sourced rounds
All 4 rounds ↓Signals
About A2 Biotherapeutics
Our T cells target solid tumors with precision, transforming the future of medicine.
A2 Biotherapeutics | 2568 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $80M | — | fundraisingfox.com | |
| Series B+ | $62M | — | endpts.com | |
| Series B+ | $71.5M | — | zpr.io | |
| Series A | $57M | — | finsmes.com |
Timeline
- Website created
Founders and team
AK
Alexander Kamb Founder- AHAgi Hamburger Senior Director Drug Discovery
- HXHan Xu Sr Director Technology
MB
Madhavan Balachandran Independent DirectorDL
David Lucas Vice President OperationsMK
Michelle Kreke Vice President, Head of Technical Operations
Investors
CCasdin Capital
- EEuclidean Capital
- HHartford HealthCare Endowment
NNextech Invest
SS32
SSamsara Biocapital
SScaleReady
TThe Column Group
UUC InvestmentsVVida Ventures
Companies like A2 Biotherapeutics
BBreakthru Medicine$60M Series A · Feb 2026
CCatalYm$150M Series B+ · Jul 2024
NNormunity$75M Series B+ · Jan 2025
AArsenal BiosciencesSeries B+ · Oct 2025PPushCART TherapeuticsSeed · Jul 2026
FFrontier MedicinesSeries B+ · Aug 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/a2-biotherapeutics (get a free API key).